Goals:

This program was developed for oncology healthcare professionals to provide information about the latest antiemetic research and guidelines for the management of chemotherapy induced nausea and vomiting.  This activity will enrich the oncology healthcare professional's contribution to quality healthcare by promoting evidence based practice for optimal patient outcomes.

Objectives:

•  Identify antiemetic guidelines for the management of chemotherapy induced nausea and vomiting.
  
•  Explore research on antiemetic agents for breakthrough nausea and vomiting.
  
•  Describe the practice patterns and awareness of 5-HT3 antiemetics for both acute and delayed CINV.
  

1.2 Contact hours awarded for successful completion

Contact our office
for further
information and pricing.